News Archive
When it comes to finding new treatments for disease, reinventing the wheel is not always necessary - drugs already in use for other conditions may do the job.
Four healthy lifestyle factors - never smoking, maintaining a healthy weight, exercising regularly and following a healthy diet - together appear to be associated with as much as an 80 percent reduction in the risk of developing the most common and deadly chronic diseases, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Scientists at Luna's nanoWorks Division in Danville, VA, have been developing a portfolio of new candidates based on antioxidant nanomaterials which could lead to a platform technology for treating a wide range of diseases. "One of our new nanomedicine prototypes, after only two weeks of treatment, was found to increase the number of hair follicles fourfold in mice which are born genetically hairless," said Robert Lenk, President of Luna's nanoWorks Division.
Lippincott Williams & Wilkins, one of the country's leading publishers of medical and health journals, today announced the release of "The Editors Handbook: An Online Resource and CE Course," providing expertise in healthcare journal editing, with a particular emphasis on nursing journal content.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
› Verified 8 days ago